Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

BACKGROUND: Recent studies strongly suggest that due to the limitations and risks of biopsy, as well as the improvement of the diagnostic accuracy of biochemical markers, liver biopsy should no longer be considered mandatory in patients with chronic hepatitis C. In 2001, FibroTest ActiTest (FT-AT),...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Comp Hepatol
Principais autores:	Poynard, Thierry, Imbert-Bismut, Françoise, Munteanu, Mona, Messous, Djamila, Myers, Robert P, Thabut, Dominique, Ratziu, Vlad, Mercadier, Anne, Benhamou, Yves, Hainque, Bernard
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2004
Assuntos:	Research
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC522750/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15387887/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1476-5926-3-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!